Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
35M
-
Shares change
-
+12.8M
-
Total reported value, excl. options
-
$135M
-
Value change
-
+$49.5M
-
Put/Call ratio
-
1.5
-
Number of buys
-
47
-
Number of sells
-
-8
-
Price
-
$3.87
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2019
70 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2019.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35M shares
of 237M outstanding shares and own 14.76% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.5M shares), Consonance Capital Management LP (5.71M shares), Aisling Capital LLC (3.61M shares), VANGUARD GROUP INC (2.45M shares), Schonfeld Strategic Advisors LLC (2.17M shares), BlackRock Inc. (1.9M shares), 683 Capital Management, LLC (1.42M shares), Jefferies Group LLC (765K shares), Broadfin Capital, LLC (748K shares), and Alyeska Investment Group, L.P. (585K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.